[1] WANG F, ZHANG YY.Practical Antiinfective Therapeutics[J]. Chinese Journal of Medicine(中国医刊), 2021, 56(2): 233. [2] SCHATTNER A, DUBIN I. Ceftriaxone Near-Fatal Anaphylaxis[J/OL]. Postgrad Med J, (2024-05-31)[2024-08-28]. https://doi.org/10.1093/postmj/qgae0662024. [3] SHARMA A, CHAMBERLAIN S, MANNURU D, et al.An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone[J]. Cureus, 2021, 13(12): e20682. [4] ZHANG HF, RAO HC.Ceftriaxone Sodium Induced Hemolytic Anemia with Condensation Syndrome: A Case report[J]. Laboratory Medicine and Clinic(检验医学与临床), 2021, 18(17): 2623-2624. [5] XU ZK, YU FH, LI L, et al.One Case of Adult Hemolysis Caused by Ceftriaxone Sodium[J]. Journal of Shandong University Health Sciences(山东大学学报医学版), 2022, 60(11): 127-129. [6] QIN D, MA WD, ZHOU HY.Identification and Detection of Hemolytic Crisis Caused by Ceftiaxone Drug antibody: A Case Report[J]. Chinese Journal of Blood Transfusion(中国输血杂志), 2022, 35(1): 105-107. [7] DICARO MV, CHEN C, WANG S, et al.Ceftriaxone-Induced Hemolytic Anemia: A Rare and Fatal Reaction[J]. Cureus, 2024, 16(5): e59646. [8] WANG HJ, YE WF, YANG JF, et al.Ceftriaxone-Related Autoimmune Hemolytic Anemia:a Case Report[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2023, 29(3): 65-66. [9] TAO E, ZHOU H, ZHENG M, et al.Ceftriaxone-Induced Severe Hemolytic Anemia, Renal Calculi, and Cholecystolithiasis in A 3-Year-Old Child: A Case Report and Literature Review[J]. Front Pharmacol, 2024, 15: 1362668. [10] CHEN JJ, QIAN PP, CAO K, et al.Comparison and Analysis of Causality Assessment Method in China and Naranjo’s Method in The Evaluation of Adverse Drug Reactions[J]. Chinese Pharmaceutical Affairs(中国药事), 2020, 34(8): 988-992. [11] MAQUET J, LAFAURIE M, MICHEL M, et al.Drug Induced Immune Hemolytic Anemia: Detection of New Signals and Risk Assessment in a Nationwide Cohort Study[J]. Blood Adv, 2024, 8(3): 817-826. [12] XIE Y, DU S, ZHU YK.Literature Analysis of Cephalosporin-Induced Hemolytic Anemia in Children[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2020, 29(11): 787-791. [13] HE YX, ZHAO HM, XUE B.Clinical Analysis of Misdiagnosis of Drug-Induced Hemolytic Anemia[J]. Clinical Misdiagnosis & Mistherapy(临床误诊误治), 2019, 32(6): 1-4. [14] ZENG L, WANG C, JIANG M, et al.Safety of Ceftriaxone in Paediatrics: A Systematic Review[J]. Arch Dis Child, 2020, 105(10): 981-985. [15] BOILEVE A, GAVAUD A, GRIGNANO E, et al.Acute and Fatal Cephalosporin-Induced Autoimmune Haemolytic Anaemia[J]. Br J Clin Pharmacol, 2021, 87(4): 2152-2156. [16] DARA RC, SHARMA R, BHARDWAJ H.Severe Drug-Induced Immune Hemolysis Due to Ceftriaxone[J]. Asian J Transfus Sci, 2020, 14(2): 187-191. [17] WANG F, LI YH, GUO RF, et al.Literature Analysis of 376 Cases of Adverse Drug Reactions Induced by Ceftriaxone Sodium for Injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(5): 289-292. [18] LOU C, LIU M, MA T, et al.Case Report: Decreased Hemoglobin and Multiple Organ Failure Caused by Ceftizoxime-Induced Immune Hemolytic Anemia in a Chinese Patient with Malignant Rectal Cancer[J]. Front Immunol, 2024, 15: 1390082. [19] BARCELLINI W, FATTIZZO B.Novel Pharmacotherapy for Drug-Induced Immune Hemolytic Anemia[J]. Expert Opin Pharmacother, 2023, 24(18): 1927-1931. |